CN100542598C - A kind of anti-tumor drug - Google Patents
A kind of anti-tumor drug Download PDFInfo
- Publication number
- CN100542598C CN100542598C CNB2006100474338A CN200610047433A CN100542598C CN 100542598 C CN100542598 C CN 100542598C CN B2006100474338 A CNB2006100474338 A CN B2006100474338A CN 200610047433 A CN200610047433 A CN 200610047433A CN 100542598 C CN100542598 C CN 100542598C
- Authority
- CN
- China
- Prior art keywords
- radix
- curcumae
- tumor
- rhizoma
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of anti-tumor drug is to belong to Chinese medicine.The present invention just provides a kind of good therapeutic effect that has, the anti-tumor drug that has no side effect.Crude drug of the present invention is Radix Astragali 10g-25g, Radix Paeoniae Alba 10g-20g, Rhizoma Curcumae 15g-30g, Radix Angelicae Sinensis 15g-25g, spend SHECAO 15g-25g, Radix Glycyrrhizae 10g-30g, Polyporus 15g-25g, Radix Bupleuri 10g-25g, Radix Curcumae 10g-20g, Herba Portulacae Grandiflorae 15g-20g, Zaocys 15g-30g, 3 of Scorpios, Spica Prunellae 10g-25g, Radix Pseudostellariae 10g-20g, Radix Gentianae 10g-25g, Fructus Amomi 15g-25g, Rhizoma Corydalis 10g-20g in vain.
Description
Technical field:
The present invention belongs to Chinese medicine.
Background technology:
Multiple antitumor drug is arranged in the market, the medicine that has has recurrence and shifts after taking a period of time sign, and the medicine that has can only temporarily play mitigation, and the efficacy of a drug is not lasting, and lethality is not strong, can't effect a radical cure tumor; And mostly antitumor drug strong toxicity, side effect are big, even human body is worked the mischief.
Summary of the invention:
The present invention is exactly at the problems referred to above, provides a kind of good therapeutic effect that has, the anti-tumor drug that has no side effect.
The present invention adopts following technical scheme, and crude drug of the present invention is Radix Astragali 10g-25g, Radix Paeoniae Alba 10g-20g, Rhizoma Curcumae 15g-30g, Radix Angelicae Sinensis 15g-25g, spend SHECAO 15g-25g, Radix Glycyrrhizae 10g-30g, Polyporus 15g-25g, Radix Bupleuri 10g-25g, Radix Curcumae 10g-20g, Herba Portulacae Grandiflorae 15g-20g, Zaocys 15g-30g, 3 of Scorpios, Spica Prunellae 10g-25g, Radix Pseudostellariae 10g-20g, Radix Gentianae 10g-25g, Fructus Amomi 15g-25g, Rhizoma Corydalis 10g-20g in vain.
The beneficial effect of the invention:
It is remarkable that the present invention can suppress killing tumor cell; The present invention eliminates the tumor focus position, removes residual tumor cell in the blood; The tumor of the tumor patient of phase morning, noon and afternoon there is powerful lethal effect and prevents the tumor cell diffusion, shifts, remove the threat that tumor causes patient's life.
Take this medicine and can improve the immunity of body, eliminate perform the operation, puts, chemotherapy (reacts the heart, lung, the damage of kidney device etc. as leucocytes reduction, bone marrow depression intestinal to damage and toxic and side effects that patient's body causes.Prevent Normocellular sudden change (canceration)), prophylaxis of tumours takes place.
Clinical proof, the comprehensive effective percentage that medicine of the present invention suppresses tumor is 91.3%, wherein the pulmonary carcinoma effective percentage 98.5%, gastric cancer effective percentage 98%, hepatocarcinoma effective percentage 98%, intestinal cancer effective percentage 99%, other tumors and blood, lymph tumor inhibition effective percentage also have comparatively satisfied effect.
Clinical experiment through for many years shows that medicine of the present invention is without any side effects, and its raw material adopts the Chinese crude drug of pure natural fully, has quick elimination lump, removes the effect of blood tumors remaining cell.
The specific embodiment:
The present invention adopts the conventional prescription method of producing to produce.
Embodiment 1:
Radix Astragali 10g, Radix Paeoniae Alba 10g, Rhizoma Curcumae 15g, Radix Angelicae Sinensis 15g, spend SHECAO 15g, Radix Glycyrrhizae 10g, Polyporus 15g, Radix Bupleuri 10g, Radix Curcumae 10g, Herba Portulacae Grandiflorae 15g, Zaocys 15g, 1 of Scorpio, Spica Prunellae 10g, Radix Pseudostellariae 10g, Radix Gentianae 10g, Fructus Amomi 15g, Rhizoma Corydalis 10g in vain.
Embodiment 2:
Radix Astragali 15g, Radix Paeoniae Alba 15g, Rhizoma Curcumae 25g, Radix Angelicae Sinensis 20g, spend SHECAO 20g, Radix Glycyrrhizae 25g, Polyporus 20g, Radix Bupleuri 15g, Radix Curcumae 15g, Herba Portulacae Grandiflorae 18g, Zaocys 25g, 2 of Scorpios, Spica Prunellae 20g, Radix Pseudostellariae 15g, Radix Gentianae 20g, Fructus Amomi 20g, Rhizoma Corydalis 15g in vain.
Embodiment 3:
Radix Astragali 25g, Radix Paeoniae Alba 20g, Rhizoma Curcumae 30g, Radix Angelicae Sinensis 25g, spend SHECAO 25g, Radix Glycyrrhizae 30g, Polyporus 25g, Radix Bupleuri 25g, Radix Curcumae 20g, Herba Portulacae Grandiflorae 20g, Zaocys 30g, 3 of Scorpios, Spica Prunellae 25g, Radix Pseudostellariae 20g, Radix Gentianae 25g, Fructus Amomi 25g, Rhizoma Corydalis 20g in vain.
Case 1:
Shen Xiuying, woman 65 years old lives in the family members institute of Changchun civil aviaton.Phone 7096823, first visit, JIUYUE in 1998 stomachache on the 20th is repeatedly checked to gynecological unbearably, does not find focus, after have blood in stool, find intestinal cancer 4.1cm * 3cm, leukopenia to tumour hospital.Take medicine of the present invention in March, 1999, up to now never recurrence.
Case 2:
Bavin is refined, man 52 years old, hepatocarcinoma, find that upper abdomen has lump June, B ultrasonic shows that the lump size is 5.9cm * 4.3cm, can just reach right of the hard portal vein of matter has cancer embolus to form to be diagnosed as primary hepatocarcinoma, previously the hepatitis B medical history to be arranged 8 years, and the negative red tongue of shifting dullness, pregnant jaundice, CT examination leftlobe of liver and the huge hepatocarcinoma of lobus dexter are arranged before the treatment, and (11cm * 7cm) is inhomogeneous diffusion.Belong to the strongly fragrant nodal pattern of blood stasis, took medicine of the present invention 1 month, the feeling of patient stomachache, abdomen account alleviates, and weak improvement, body weight increase to some extent, and abdominal CT shows that leftlobe of liver and lobus dexter lump obviously reduce, and disappears to 6cm * 4cm portal vein tumor thrombus, and it is still alive that phone is followed up a case by regular visits to the people.Live No. 18 Provincial Party committee's dormitories in Lu Xi alleyway, Bei'an, phone 8946598.
Case 3:
Gao Shenju, woman 52 years old, ovarian cancer, on March 5th, 1999, because of ovarian cancer row full uterus double accessory and omentum resection, systemic chemotherapy was found tumor recurrence and transfer in April, 2000 simultaneously, carried out the 2nd operation April 15.August 25 began to take medicine of the present invention, the tumor at JIUYUE color ultrasound examination demonstration on the 29th recurrent focus position is obviously dwindled the metastasis complete obiteration.Live red flag street two dormitories, phone 5929025.
Just 80% the tumor cell of excision, remaining 20% tumor cell is in free state in vivo and does not form tumor, and after after a while, they breed fast, get together again after breeding some by the time, form new tumor; Medicine of the present invention can effectively soften and dwindle tumor, reduces perineural compressing, reduces the toxin that the tractive of internal organs such as liver, kidney, pancreas and burden repeatedly absorb tumor is got rid of external liver, the nephrotoxicity of preventing rapidly.Eliminate hydrops from the source, make tumor constantly soften, dwindle, effectively control the generation of transfer, recurrence and the hydrops of tumor until disappearance.
Claims (3)
1, a kind of anti-tumor drug is characterized in that crude drug is Radix Astragali 10g-25g, Radix Paeoniae Alba 10g-20g, Rhizoma Curcumae 15g-30g, Radix Angelicae Sinensis 15g-25g, spends SHECAO 15g-25g, Radix Glycyrrhizae 10g-30g, Polyporus 15g-25g, Radix Bupleuri 10g-25g, Radix Curcumae 10g-20g, Herba Portulacae Grandiflorae 15g-20g, Zaocys 15g-30g, 3 of Scorpios, Spica Prunellae 10g-25g, Radix Pseudostellariae 10g-20g, Radix Gentianae 10g-25g, Fructus Amomi 15g-25g, Rhizoma Corydalis 10g-20g in vain.
2, a kind of anti-tumor drug is characterized in that crude drug is Radix Astragali 10g, Radix Paeoniae Alba 10g, Rhizoma Curcumae 15g, Radix Angelicae Sinensis 15g, spends SHECAO 15g, Radix Glycyrrhizae 10g, Polyporus 15g, Radix Bupleuri 10g, Radix Curcumae 10g, Herba Portulacae Grandiflorae 15g, Zaocys 15g, 1 of Scorpio, Spica Prunellae 10g, Radix Pseudostellariae 10g, Radix Gentianae 10g, Fructus Amomi 15g, Rhizoma Corydalis 10g in vain.
3, a kind of anti-tumor drug is characterized in that crude drug is Radix Astragali 15g, Radix Paeoniae Alba 15g, Rhizoma Curcumae 25g, Radix Angelicae Sinensis 20g, spends SHECAO 20g, Radix Glycyrrhizae 25g, Polyporus 20g, Radix Bupleuri 15g, Radix Curcumae 15g, Herba Portulacae Grandiflorae 18g, Zaocys 25g, 2 of Scorpios, Spica Prunellae 20g, Radix Pseudostellariae 15g, Radix Gentianae 20g, Fructus Amomi 20g, Rhizoma Corydalis 15g in vain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100474338A CN100542598C (en) | 2006-08-11 | 2006-08-11 | A kind of anti-tumor drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100474338A CN100542598C (en) | 2006-08-11 | 2006-08-11 | A kind of anti-tumor drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101121010A CN101121010A (en) | 2008-02-13 |
| CN100542598C true CN100542598C (en) | 2009-09-23 |
Family
ID=39083648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100474338A Expired - Fee Related CN100542598C (en) | 2006-08-11 | 2006-08-11 | A kind of anti-tumor drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100542598C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361939B (en) * | 2008-09-23 | 2010-11-17 | 郭掌印 | Malignant tumor treating medicine |
| CN103961643B (en) * | 2014-04-28 | 2017-09-26 | 孙沈平 | One Zhong Linshi supports positive disperse accumulations pellet and its application |
| CN105012427A (en) * | 2015-07-05 | 2015-11-04 | 吴优 | Softgel for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| CN105617137A (en) * | 2016-03-07 | 2016-06-01 | 李晓晓 | Traditional Chinese medicine for treating thyroid cancer |
| CN107184912A (en) * | 2017-06-22 | 2017-09-22 | 孙沈平 | The positive disperse accumulations compound preparation of one breeding and its application |
-
2006
- 2006-08-11 CN CNB2006100474338A patent/CN100542598C/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 益气养阴药与活血行气药配伍治疗原发性肝癌的理论探讨及实验研究. 丁荣杰.南京中医药大学研究生毕业论文. 2005 |
| 益气养阴药与活血行气药配伍治疗原发性肝癌的理论探讨及实验研究. 丁荣杰.南京中医药大学研究生毕业论文. 2005 * |
| 脑肿瘤一例治验. 岳泽明.四川中医，第5期. 1986 |
| 脑肿瘤一例治验. 岳泽明.四川中医，第5期. 1986 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101121010A (en) | 2008-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103861079B (en) | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors | |
| CN100542598C (en) | A kind of anti-tumor drug | |
| CN104491740A (en) | Traditional Chinese medicine composition for treating liver cancer and preparation method of traditional Chinese medicine composition | |
| CN104189428A (en) | Traditional Chinese medicinal preparation for treating proliferation of mammary glands | |
| CN103536826B (en) | One is treated colpitic Chinese medicine composition and preparation method thereof | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN101168003A (en) | Traditional Chinese medicinal composition for preparing medicine for preventing and treating gynopathy | |
| CN111097030A (en) | Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof | |
| CN102225182B (en) | Traditional Chinese preparation capable of inhibiting tumor and enhancing immunity and preparation method thereof | |
| CN104173920A (en) | Medicine for treating lymphoma | |
| CN104784508B (en) | For improving the preparation method of the Chinese medicine preparation of malignant tumor patient immunologic function | |
| CN103520656A (en) | Traditional Chinese medicine composition for treating pancreatic cancer | |
| CN103330781A (en) | Traditional Chinese medicine composite with anti-tumor effect and preparation method of injection of same | |
| CN103495061B (en) | Traditional Chinese medicine composition for treating cholecystitis caused by stagnation of liver qi and phlegm and blood stasis | |
| CN103385943B (en) | Chinese medicine of a kind of Therapeutic cancer and preparation method thereof | |
| CN105770691A (en) | Medicinal preparation for treating cervical cancer and application thereof | |
| CN101337043B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN104800764A (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method | |
| CN103784689A (en) | Medicinal composition for treating leukemia | |
| CN104027447A (en) | Traditional Chinese medicine for treating cancer | |
| CN104524425A (en) | Traditional Chinese medicine decoction for treating pancreatic pseudocyst | |
| CN103028028B (en) | Traditional Chinese medicine agent for treating primary hepatic carcinoma | |
| CN108653497A (en) | A kind of Chinese medicine composition for treating oophoroma | |
| CN105106479A (en) | Traditional Chinese medicine for preventing and treating injury caused by extravasation of chemotherapeutic drugs and multifunctional stirring device | |
| CN104398704A (en) | Traditional Chinese medicine composition for treating stomach cancer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090923 Termination date: 20170811 |